MYGN Operating Cash Flow Growth
Myriad Genetics Inc · Operating Cash Flow Growth
MYGN Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported134.07%period ending
MYGN TTM Cash from Operations YoY % (9.30% → 134.07%)
Year-over-year change
High-resolution chart · PNG
MYGN operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 134.0708% | |
| 137.5% | |
| 120.6897% | |
| 96.8571% | |
| 75.6466% | |
| 93.3541% | |
| 92.1551% | |
| -9.5462% | |
| -108.0717% | |
| -3.1049% | |
| -3.9363% | |
| 41.3223% | |
| 69.326% | |
| 6.6933% | |
| -686.2637% | |
| -894.8905% | |
| -2,207.9365% | |
| -456.2278% | |
| 167.658% | |
| 195.1389% | |
| -110.3789% | |
| -54.8232% | |
| -151.7308% | |
| -115.7034% | |
| -27.4791% | |
| -37.8621% | |
| -50.4762% | |
| -8.483% | |
| -27.7826% | |
| -4.3021% | |
| -21.7586% | |
| -24.4344% | |
| 9.1337% | |
| -16.9841% | |
| 2.5994% | |
| -12.4752% | |
| -42.3453% | |
| -29.5475% | |
| -19.6777% | |
| -7.251% | |
| 31.0622% | |
| 37.1156% | |
| 45.68% | |
| 53.0427% | |
| -26.1123% | |
| -38.5562% | |
| -53.1169% | |
| -49.8897% | |
| 9.4021% | |
| 39.1033% | |
| 52.88% | |
| 31.9874% | |
| 22.5781% | |
| 11.8788% | |
| 26.085% | |
| 21.0718% | |
| 8.4751% | |
| -3.2459% | |
| -20.5059% | |
| -17.3163% | |
| -15.6861% | |
| -4.4165% | |
| 38.0574% | |
| 44.4169% | |
| 84.5339% | |
| -6.0273% | |
| -26.5893% | |
| -0.3686% | |
| -18.9847% | |
| 2,099.4013% | |
| 991.8269% | |
| 562.0381% | |
| 501.2843% | |
| 73.293% | |
| 45.107% | |
| 22.7229% | |
| 7.7639% | |
| -26.4868% | |
| -25.2586% | |
| -39.5819% | |
| -20.2669% | |
| 25.7335% | |
| 5.8689% | |
| 22.4266% | |
| 24.5337% | |
| -21.1476% | |
| 32.779% | |
| 31.2577% | |
| 33.6485% | |
| 36.6816% | |
| -30.543% | |
| -71.7216% | |
| -185.3107% | |
| -142.9252% | |
| -247.8943% | |
| -195.4638% | |
| -332.072% | |
| -579.634% | |
| -214.3037% | |
| -332.4178% |